Lung cancer, Non small cell lung cancer (NSCLC)
Open
Phase 3
This trial is looking at pembrolizumab with or without an drug called V940 for non small cell lung cancer.
It is open to people whose cancer can be removed with surgery.
Recruitment start: 21 November 2024
Recruitment end: 30 November 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sanjaykumar Popat
Merck Sharp & Dohme LLC
Last reviewed: 4 September 2025
CRUK internal database number: 19992
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
